This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo
Book Now
Menu
Book Now

Kousaku Ohinata, PhD
Founder and Scientific Advisor at Viage Therapeutics
Speaker

Agenda Sessions

  • First-in-Class Drug Candidate Targeting Gut AVPR1a receptor for Dual Antidepressant and Pro-Cognitive Efficacy

    , 12:00pm
    View Session

At this event

Prev
Next
Chris Oswald
Founder, Owner, and Principal Consultant
Coswald Consulting LLC

See Kousaku at TIDES Asia: Oligonucleotide & Peptide Therapeutics

Book Now